Ocugen, Inc. (OCGN)
NASDAQ: OCGN · IEX Real-Time Price · USD
1.660
+0.025 (1.53%)
Jul 19, 2024, 4:00 PM EDT - Market closed

Ocugen Revenue

Ocugen had revenue of $7.05M in the twelve months ending March 31, 2024, with 140.53% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.01M with 128.89% year-over-year growth. In the year 2023, Ocugen had annual revenue of $6.04M with 142.60% growth.

Revenue (ttm)
$7.05M
Revenue Growth
+140.53%
P/S Ratio
60.60
Revenue / Employee
$108,462
Employees
65
Market Cap
427.21M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.04M3.55M142.60%
Dec 31, 20222.49M--
Dec 31, 20210--
Dec 31, 202043.00K--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 201226.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sonida Senior Living 260.69M
Voyager Therapeutics 119.04M
EyePoint Pharmaceuticals 50.02M
Taysha Gene Therapies 14.16M
Nano-X Imaging 10.01M
Altimmune 410.00K
Revenue Rankings